The company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended a conditional approval of Erivedge (vismodegib) for the treatment of adult patients with symptomatic metastatic basal cell carcinoma. Strong technical buy at stoxline website.
It would be fairly valued at $14.85/ share. This valuation is based off of their stellar earnings report, and what its peer China HGS Real Estate (HGSH) is trading at. Strong buy at allchinastocks website.
The Coca Cola Company has rolled out a project for the distribution of solar panels to operators of the firm’s soft drink kiosks. Watch for the technical breakout of 42.7 according to foxchart website